AABB reserves the right to make updates to this program.
Please note: This program is eligible for 0.75 continuing education credits for Physicians and General Participation credits. California Lab Personnel (CLP), Florida Lab Personnel (FLP) and California Nurse (CN) credits are not eligible due to program length. For further clarification please contact
Live Program Date: Wednesday, April 11, 2018 -
Master Program Number: 18EL-327 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Hospitals, Hospital Blood Banks, Laboratory Staff, Managers/Supervisors, Medical Director, Perfusionists, Physicians, Resident/Fellow, Technologists, Transfusion Safety Officer
Teaching Level: Intermediate
Director/Moderator: Kerry L. O’Brien, MD, Medical Director Blood Bank, Beth Israel Deaconess Medical Center, Boston, MA
Speaker: Daniel Kelly, MD, Intensivist, Division of Medicine Critical Care, Boston Children’s Hospital, Boston, MA
After participating in this educational activity, participants should be able to:
- Describe the ECMO circuit.
- Explain the indications for venovenous and venoarterial ECMO in the adult patient.
- Detail the indications for blood product replacement in the adult patient on ECMO.
- Recognize the complications associated with ECMO.
The indications for venovenous (VV) and venoarterial (VA) extracorporeal membrane oxygenation (ECMO) in the adult patient as well as the technical differences between each mode will be discussed during this program. Blood product support and laboratory testing recommendations of adult patients on ECMO will be reviewed.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||
Continuing Education Credit
AABB designates both the live and on-demand version of this eCast each eligible for 0.75 continuing education credits for Physicians and General Participation credits. The number and type of credits awarded for this program (both live and on-demand) was determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.
Dr. Daniel Kelly is the Associate Medical Director for Safety and Quality in the Division of Medicine Critical Care at Boston Children’s Hospital. A graduate of Brown University and Brown University Medical School, he completed Pediatrics residency at New York Presbyterian Hospital, Pediatric Critical Care Fellowship at Boston Children’s Hospital followed by Transfusion Medicine Fellowship in the Harvard Joint Program in Transfusion Medicine. He is a member of the faculty of Harvard Medical School and a Pediatric Intensivist at Boston Children’s Hospital. His research interests include pediatric transfusion practice, coagulation and hemolysis in extracorporeal membrane oxygenation, and immune effects of transfusion.